PEGylation, successful approach to drug delivery

被引：1880

作者：

Veronese, FM ^{[1
]}

Pasut, G ^{[1
]}

机构：

[1] Univ Padua, Dept Pharmaceut Sci, I-35128 Padua, Italy

来源：

DRUG DISCOVERY TODAY | 2005年 / 10卷 / 21期

关键词：

D O I：

10.1016/S1359-6446(05)03575-0

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PEGylation defines the modification of a protein, peptide or non-peptide molecule by the linking of one or more polyethylene glycol (PEG) chains. This polymer is nontoxic, non-immunogenic, non-antigenic, highly soluble in water and FDA approved. The PEG-drug conjugates have several advantages: a prolonged residence in body, a decreased degradation by metabolic enzymes and a reduction or elimination of protein immunogenicity. Thanks to these favorable properties, PEGylation now plays an important role in drug delivery, enhancing the potentials of peptides and proteins as therapeutic agents.

引用

页码：1451 / 1458

页数：8

共 49 条

[1]

ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582

[2]

ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578

[3] Rational design of a potent, long-lasting form of interferon:: A 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C [J].

Bailon, P ;

Palleroni, A ;

Schaffer, CA ;

Spence, CL ;

Fung, WJ ;

Porter, JE ;

Ehrlich, GK ;

Pan, W ;

Xu, ZX ;

Modi, MW ;

Farid, A ;

Berthold, W .

BIOCONJUGATE CHEMISTRY, 2001, 12 (02) :195-202

[4]

BERNA M, 2005, 32 ANN M EXP CONTR R

[5]

BOLDER BIOTECHNOLOGY INC, 1999, WO patent, Patent No. 9903887

[6] ACTIVE-SITE PROTECTION OF PROTEOLYTIC-ENZYMES BY POLY(ETHYLENE GLYCOL) SURFACE MODIFICATION [J].

CALICETI, P ;

SCHIAVON, O ;

SARTORE, L ;

MONFARDINI, C ;

VERONESE, FM .

JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 1993, 8 (01) :41-50

[7] Therapeutic antibody fragments with prolonged in vivo half-lives [J].

Chapman, AP ;

Antoniw, P ;

Spitali, M ;

West, S ;

Stephens, S ;

King, DJ .

NATURE BIOTECHNOLOGY, 1999, 17 (08) :780-783

[8] Nature-inspired creation of protein-polysaccharide conjugate and its subsequent assembly onto a patterned surface [J].

Chen, TH ;

Small, DA ;

Wu, LQ ;

Rubloff, GW ;

Ghodssi, R ;

Vazquez-Duhalt, R ;

Bentley, WE ;

Payne, GF .

LANGMUIR, 2003, 19 (22) :9382-9386

[9] Anticancer drug delivery systems:: multi-loaded N4-acyl poly(ethylene glycol) prodrugs of ara-C.: II.: Efficacy in ascites and solid tumors [J].

Choe, YH ;

Conover, CD ;

Wu, DC ;

Royzen, M ;

Gervacio, Y ;

Borowski, V ;

Mehlig, M ;

Greenwald, RB .

JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :55-70

[10]

DEFREES S, 2004, Patent No. 2004099231

← 1 2 3 4 5 →